touchpodcast
touchPODCAST
Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005!We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updatesHome...
Vizitează neapărat site-ul podcastului și susține-i creatorul: touchpodcast.podbean.com
Autor
touchpodcast
Categorie
Site-ul podcastului
Cel mai nou episod
16 oct. 2026
Unde asculți?
Podcasturi în aplicație Replaio Radio În curândPodcasturile ajung în curând în aplicație. Instaleaz-o acum și fii primul care descoperă o abordare complet nouă a podcasturilor
Episoade
Addressing the diagnosis and management of pet allergies in primary care and beyond 14.02.2024 16:56
touchFOCUS for touchRESPIRATORY Dr Ann-Marie Schoos answers a series of questions on the diagnosis and management of pet allergies, including the role of component-resolved diagnostics in providing a detailed analysis of patients' sensitization profiles to allow for a more personalized approach to management. The expert: Dr Ann-Marie Schoos - University of Copenhagen, Denmark This touchPODCAST is...
Addressing the diagnosis and management of pet allergies in primary care and beyond 09.02.2024 16:56
touchFOCUS for touchIMMUNOLOGY Dr Ann-Marie Schoos answers a series of questions on the diagnosis and management of pet allergies, including the role of component-resolved diagnostics in providing a detailed analysis of patients' sensitization profiles to allow for a more personalized approach to management. The expert: Dr Ann-Marie Schoos - University of Copenhagen, Denmark This touchPODCAST is f...
The rationale for protein degradation and immunomodulation in RRMM: Highlighting the latest data and available clinical trials 09.02.2024 34:04
touchEXPERT OPINIONS for touchHAEMATOLOGY Three internationally renowned multiple myeloma experts share insights into the unmet treatment needs for patients with relapsed/refractory multiple myeloma, the rationale for emerging protein degradation and immunomodulation-based therapies, and the latest data and ongoing clinical trials for these investigational agents. The experts Prof. Cristina Gasp...
The rationale for protein degradation and immunomodulation in RRMM: Highlighting the latest data and available clinical trials 09.02.2024 34:04
touchEXPERT OPINIONS for touchONCOLOGY Three internationally renowned multiple myeloma experts share insights into the unmet treatment needs for patients with relapsed/refractory multiple myeloma, the rationale for emerging protein degradation and immunomodulation-based therapies, and the latest data and ongoing clinical trials for these investigational agents. The experts Prof. Cristina Gaspare...
Diagnosing and treating patients with EoE: Tackling the difficulties 07.02.2024 35:22
touchEXPERT OPINIONS for touchIMMUNOLOGY Three experts discuss the challenges related to recognizing, diagnosing and treating patients with eosinophilic oesophagitis (EoE) and highlight how advances in diagnostic tools and emerging treatments may impact future care. The experts: Dr Efrem Eren, Southampton General Hospital, UK Dr Nirmala Gonsalves, Northwestern University Feinberg School of Medicin...
Diagnosing and treating patients with EoE: Tackling the difficulties 07.02.2024 35:21
touchEXPERT OPINIONS for touchRESPIRATORY Three experts discuss the challenges related to recognizing, diagnosing and treating patients with eosinophilic oesophagitis (EoE) and highlight how advances in diagnostic tools and emerging treatments may impact future care. The experts: Dr Efrem Eren, Southampton General Hospital, UK Dr Nirmala Gonsalves, Northwestern University Feinberg School of Medici...
touchMDT – Patient-centric care for prurigo nodularis – Discussion 3 06.02.2024 14:19
touchMDT for touchIMMUNOLOGY Listen to expert and patient perspectives on the importance of a holistic, multidisciplinary approach in establishing optimal treatment and care pathways for patients with prurigo nodularis. The multidisciplinary team Dermatologist: Prof. Martin Mertz, Berlin, Germany Dermatologist: Dr Manuel Pereira, Berlin, Germany Psychodermatologist: Prof. Anthony Bewley, London, U...
touchMDT – Management of prurigo nodularis – Discussion 2 06.02.2024 14:24
touchMDT for touchIMMUNOLOGY Listen to expert perspectives on the current and emerging treatment landscape for prurigo nodularis. The multidisciplinary team Dermatologist: Prof. Martin Mertz, Berlin, Germany Dermatologist: Dr Manuel Pereira, Berlin, Germany Psychodermatologist: Prof. Anthony Bewley, London, UK This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independe...
touchMDT – Burden of prurigo nodularis – Discussion 1 06.02.2024 13:53
touchMDT for touchIMMUNOLOGY Listen to expert and patient perspectives on the burden and unmet clinical needs associated with prurigo nodularis. The multidisciplinary team Dermatologist: Prof. Martin Mertz, Berlin, Germany Dermatologist: Dr Manuel Pereira, Berlin, Germany Psychodermatologist: Prof. Anthony Bewley, London, UK Patient advocate: Ms Sailaja Maganti, London, UK This touchPODCAST is for...
touchMDT – Patient-centric care for prurigo nodularis – Discussion 3 06.02.2024 14:20
touchMDT for touchDERMATOLOGY Listen to expert and patient perspectives on the importance of a holistic, multidisciplinary approach in establishing optimal treatment and care pathways for patients with prurigo nodularis. The multidisciplinary team Dermatologist: Prof. Martin Mertz, Berlin, Germany Dermatologist: Dr Manuel Pereira, Berlin, Germany Psychodermatologist: Prof. Anthony Bewley, London,...
touchMDT – Management of prurigo nodularis – Discussion 2 06.02.2024 14:24
touchMDT for touchDERMATOLOGY Listen to expert perspectives on the current and emerging treatment landscape for prurigo nodularis. The multidisciplinary team Dermatologist: Prof. Martin Mertz, Berlin, Germany Dermatologist: Dr Manuel Pereira, Berlin, Germany Psychodermatologist: Prof. Anthony Bewley, London, UK This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independ...
touchMDT – Burden of prurigo nodularis – Discussion 1 06.02.2024 13:53
touchMDT for touchDERMATOLOGY Listen to expert and patient perspectives on the burden and unmet clinical needs associated with prurigo nodularis. The multidisciplinary team Dermatologist: Prof. Martin Mertz, Berlin, Germany Dermatologist: Dr Manuel Pereira, Berlin, Germany Psychodermatologist: Prof. Anthony Bewley, London, UK Patient advocate: Ms Sailaja Maganti, London, UK This touchPODCAST is fo...
Is HER2 targeting on the horizon for urothelial carcinoma? 24.01.2024 16:16
touchFOCUS for touchONCOLOGY A genitourinary medical oncologist considers the potential for targeting HER2 in the treatment of urothelial carcinoma, including the rationale for HER2 as a target, approaches to HER2 testing, the latest data on emerging HER2-targeted therapies and the potential implications for future clinical practice. The expert: Dr Vadim Koshkin - University of California San Fra...
Addressing challenges in diagnosis and treatment of IgG4-related gastrointestinal disease 24.01.2024 34:56
touchIN CONVERSATION for touchIMMUNOLOGY Listen to Dr Shounak Majumder (Mayo Clinic, Rochester, MN, USA) in conversation with Professor Matthias Löhr (Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden) on how to optimize the diagnosis and management of patients with IgG4-related gastrointestinal (GI) disease. They respond to questions from the gastroenterology, hepatolog...
Haemato-oncology experts discuss current considerations and future strategies for CAR T-cell therapies in patients with R/R MCL 10.01.2024 42:55
touchIN CONVERSATION for touchONCOLOGY Listen to a conversation between haemato-oncologists Dr Matthew Matasar and Dr Amitkumar Mehta, as they respond to questions submitted by the HCP audience and provide their expert insights on the current considerations and future strategies when managing the practicalities of CAR T-cell therapies in patients with relapsed or refractory mantle cell lymphoma. T...
Haemato-oncology experts discuss current considerations and future strategies for CAR T-cell therapies in patients with R/R MCL 10.01.2024 42:55
touchIN CONVERSATION for touchHAEMATOLOGY Listen to a conversation between haemato-oncologists Dr Matthew Matasar and Dr Amitkumar Mehta, as they respond to questions submitted by the HCP audience and provide their expert insights on the current considerations and future strategies when managing the practicalities of CAR T-cell therapies in patients with relapsed or refractory mantle cell lymphoma...
Overcoming challenges in advanced or metastatic squamous cell lung cancer: Focus on immunotherapy 09.01.2024 18:42
touchFOCUS for touchONCOLOGY Listen to Dr Balazs Halmos answer a series of questions focused on the distinctive clinical features of squamous cell lung cancer, the challenges they pose to developing a treatment plan, and the role immunotherapy plays in overcoming them. The expert: Dr Balazs Halmos - Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, Bronx, NY, U...
Overcoming challenges in advanced or metastatic squamous cell lung cancer: Focus on immunotherapy 09.01.2024 18:42
touchFOCUS for touchRESPIRATORY Listen to Dr Balazs Halmos answer a series of questions focused on the distinctive clinical features of squamous cell lung cancer, the challenges they pose to developing a treatment plan, and the role immunotherapy plays in overcoming them. The expert: Dr Balazs Halmos - Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, Bronx, NY...
Haemato-oncology experts discuss managing the practicalities of CAR T-cell therapy in relapsed or refractory follicular lymphoma 08.01.2024 40:44
touchIN CONVERSATION for touchONCOLOGY Listen to Dr Nilanjan Ghosh in conversation with Dr Peter Riedell. They respond to questions submitted by the HCP audience and provide their expert insights regarding new horizons in relapsed or refractory follicular lymphoma, with a focus on risk stratification and managing the practicalities of CAR T-cell therapy. This touchPODCAST is for HCPs only. This ac...
Haemato-oncology experts discuss managing the practicalities of CAR T-cell therapy in relapsed or refractory follicular lymphoma 08.01.2024 40:45
touchIN CONVERSATION for touchHAEMATOLOGY Listen to Dr Nilanjan Ghosh in conversation with Dr Peter Riedell. They respond to questions submitted by the HCP audience and provide their expert insights regarding new horizons in relapsed or refractory follicular lymphoma, with a focus on risk stratification and managing the practicalities of CAR T-cell therapy. This touchPODCAST is for HCPs only. This...
Advances in IOL technology and power calculations: Updates and innovations 22.12.2023 17:24
touchFOCUS for touchOPHTHALMOLOGY Listen to Dr John Hovanesian answer a series of questions focused on how to effectively manage patients prior to cataract surgery and ensure the most appropriate intraocular lens (IOL) formula is used, including his views on recent advances in IOL technology. The expert: Dr John Hovanesian, University of California, Los Angeles, Jules Stein Eye Institute, CA, USA...
Guideline-based treatment of recurrent/metastatic cervical cancer 13.12.2023 35:53
touchEXPERT OPINIONS for touchONCOLOGY Two oncologists summarize the latest US and European guidelines for the treatment of recurrent/metastatic cervical cancer and a nurse practitioner considers key safety considerations for immunotherapy and targeted treatments. The experts Dr David O’Malley - James Comprehensive Cancer Center, Columbus, OH, USA Dr Domenica Lorusso - La Fondazione Policlinico U...
IgG4-related disease: How to identify, diagnose and treat 11.12.2023 48:50
touchSATELLITE SYMPOSIUM for touchIMMUNOLOGY Listen to this touchSATELLITE SYMPOSIUM recorded live in November at the ACR Convergence 2023, in San Diego, CA, USA. Prof. John Stone (USA), the chair for the symposium, is joined by Dr Emanuel Della Torre (Italy) and Dr Arezou Khosroshahi (USA). The first session, led by Prof. John Stone (02:27), focuses on the pathophysiology and varying clinical p...
Paediatric atopic dermatitis: Evolving strategies for improved management 07.12.2023 38:03
touchPANEL DISCUSSION for touchIMMUNOLOGY Listen to a panel of experts as they discuss the burden of atopic dermatitis in children and their families, when treatment escalation with systemic therapy should be considered, and how to support patients and their families to achieve long-term control of symptoms. The experts Dr Elaine Siegfried - Cardinal Glennon Children’s Hospital, St. Louis, MO, USA...
Paediatric atopic dermatitis: Evolving strategies for improved management 07.12.2023 38:02
touchPANEL DISCUSSION for touchDERMATOLOGY Listen to a panel of experts as they discuss the burden of atopic dermatitis in children and their families, when treatment escalation with systemic therapy should be considered, and how to support patients and their families to achieve long-term control of symptoms. The experts Dr Elaine Siegfried - Cardinal Glennon Children’s Hospital, St. Louis, MO, US...
Podcasturi asemănătoare
Replaio nu este editorul podcasturilor; numele emisiunilor, coperțile și materialul audio aparțin autorilor lor și sunt distribuite prin fluxuri RSS publice